<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02836886</url>
  </required_header>
  <id_info>
    <org_study_id>AAAQ9017</org_study_id>
    <nct_id>NCT02836886</nct_id>
  </id_info>
  <brief_title>VircapSeq Virus Detection in Sézary Syndrome</brief_title>
  <official_title>Searching for Oncogenic Viruses in Sézary Cells Using a Novel Viral Discovery Technique, VirCapSeq-VERT</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Columbia University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will be using this technique, called &quot;VirCapSeq-VERT&quot; to analyze the white blood
      cells of patients with Sézary syndrome. This could provide the foundation for future studies
      looking to understand the role that viruses play in the origin of Sézary syndrome. This could
      have important implications for the future development of new and effective therapies for the
      disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cutaneous T-cell lymphoma (CTCL) is a rare lymphoproliferative disorder characterized by
      malignant CD4+ T-cells that infiltrate the skin. While most cases are confined to skin, CTCL
      is also capable of affecting the blood, lymph nodes, and visceral organs. Sézary Syndrome
      (SS) is a leukemic variant of the disease with a poor prognosis and can arise with or without
      cutaneous involvement. The pathogenesis of CTCL is poorly understood, but chronic antigen
      stimulation possibly due to a bacterial or viral infection or colonization of the skin may
      lead to malignant transformation of the skin resident T cells. Colonization of the skin of
      CTCL patients with Staphylococcus aureus is common and can lead to the clonal expansion of
      malignant T cells in the skin. However, its role as an etiological agent is unlikely,
      considering commonality of S.aureus and rarity of the skin T-cell lymphomas. Mounting
      evidence suggests that oncogenic viral pathogen may play a role, but all efforts to implicate
      certain viruses, such as retroviruses or herpesviruses have yielded inconsistent results.
      This study will use the most sensitive method to date, a novel viral detection technique
      capable of detecting every known vertebrate virus in tissue samples, called &quot;Virome Capture
      Sequencing Platform for Vertebrate Viruses (VirCapSeq-VERT).&quot; This allows it to detect
      previously undiscovered viruses that diverge from known sequences by as much as 40%.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2016</start_date>
  <completion_date type="Actual">October 2016</completion_date>
  <primary_completion_date type="Actual">October 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of viral sequences present in malignant T cells of patients with Sézary syndrome</measure>
    <time_frame>Up to 1 week</time_frame>
    <description>White blood cells samples will be analyzed with technique called &quot;VirCapSeq-VERT&quot;</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">6</enrollment>
  <condition>Lymphoma, T-Cell, Cutaneous</condition>
  <condition>Sézary Syndrome</condition>
  <arm_group>
    <arm_group_label>Sézary syndrome</arm_group_label>
    <description>Patients diagnosed with Sézary syndrome diagnosed according to the WHO-EORTC criteria.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood sample: two tubes collected by standard blood draw (venipuncture) procedure. The total
      amount of blood drawn will be about two teaspoons.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with Sézary syndrome diagnosed according to the WHO-EORTC criteria.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with Sézary syndrome diagnosed according to the WHO-EORTC classification.

        Exclusion Criteria:

          -  Pregnant patients.

          -  Patients with known anemia with documented &lt;7.5 mg/dL.

          -  Patients who are unable to give informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Larisa G Geskin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Columbia University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, Ralfkiaer E, Chimenti S, Diaz-Perez JL, Duncan LM, Grange F, Harris NL, Kempf W, Kerl H, Kurrer M, Knobler R, Pimpinelli N, Sander C, Santucci M, Sterry W, Vermeer MH, Wechsler J, Whittaker S, Meijer CJ. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005 May 15;105(10):3768-85. Epub 2005 Feb 3. Review.</citation>
    <PMID>15692063</PMID>
  </reference>
  <reference>
    <citation>Siegel RS, Pandolfino T, Guitart J, Rosen S, Kuzel TM. Primary cutaneous T-cell lymphoma: review and current concepts. J Clin Oncol. 2000 Aug;18(15):2908-25. Review. Erratum in: J Clin Oncol 2001 Nov 1;19(21):4185.</citation>
    <PMID>10920140</PMID>
  </reference>
  <reference>
    <citation>Henn A, Michel L, Fite C, Deschamps L, Ortonne N, Ingen-Housz-Oro S, Marinho E, Beylot-Barry M, Bagot M, Laroche L, Crickx B, Maubec E. Sézary syndrome without erythroderma. J Am Acad Dermatol. 2015 Jun;72(6):1003-9.e1. doi: 10.1016/j.jaad.2014.11.015.</citation>
    <PMID>25981000</PMID>
  </reference>
  <reference>
    <citation>Lessin SR, Vowels BR, Rook AH. Retroviruses and cutaneous T-cell lymphoma. Dermatol Clin. 1994 Apr;12(2):243-53. Review.</citation>
    <PMID>8045036</PMID>
  </reference>
  <reference>
    <citation>Willerslev-Olsen A, Krejsgaard T, Lindahl LM, Bonefeld CM, Wasik MA, Koralov SB, Geisler C, Kilian M, Iversen L, Woetmann A, Odum N. Bacterial toxins fuel disease progression in cutaneous T-cell lymphoma. Toxins (Basel). 2013 Aug 14;5(8):1402-21. doi: 10.3390/toxins5081402. Review.</citation>
    <PMID>23949004</PMID>
  </reference>
  <reference>
    <citation>Mirvish JJ, Pomerantz RG, Falo LD Jr, Geskin LJ. Role of infectious agents in cutaneous T-cell lymphoma: facts and controversies. Clin Dermatol. 2013 Jul-Aug;31(4):423-431. doi: 10.1016/j.clindermatol.2013.01.009. Review.</citation>
    <PMID>23806159</PMID>
  </reference>
  <reference>
    <citation>Briese T, Kapoor A, Mishra N, Jain K, Kumar A, Jabado OJ, Lipkin WI. Virome Capture Sequencing Enables Sensitive Viral Diagnosis and Comprehensive Virome Analysis. MBio. 2015 Sep 22;6(5):e01491-15. doi: 10.1128/mBio.01491-15. Erratum in: MBio. 2017 May 16;8(3):.</citation>
    <PMID>26396248</PMID>
  </reference>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 15, 2016</study_first_submitted>
  <study_first_submitted_qc>July 15, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 19, 2016</study_first_posted>
  <last_update_submitted>February 6, 2017</last_update_submitted>
  <last_update_submitted_qc>February 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Columbia University</investigator_affiliation>
    <investigator_full_name>Larisa Geskin</investigator_full_name>
    <investigator_title>Associate Professor of Dermatology in Medicine at the Columbia U, Department of Dermatology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Sezary Syndrome</mesh_term>
    <mesh_term>Lymphoma, T-Cell</mesh_term>
    <mesh_term>Lymphoma, T-Cell, Cutaneous</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

